The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide
Abstract
The effect of various types of nanoliposomes (associated with curcumin, phosphatidic acid, cardiolipin, or GM1 ganglioside) on the aggregation of the amyloid-β(1-42) (Aβ(1-42)) peptide was investigated. Nanoliposomes incorporating curcumin (curcumin-liposomes) were prepared by adding curcumin in the lipid phase during liposome preparation, whereas curcumin surface-decorated liposomes were prepared by using a curcumin-lipid conjugate (lipid-S-curcumin liposomes) or by attaching a curcumin derivative on preformed liposomes by click chemistry (click-curcumin liposomes). The lipid ligands (phosphatidic acid, cardiolipin, or GM1) were also incorporated into nanoliposomes during their formation. All nanoliposomes with curcumin, or the curcumin derivative, were able to inhibit the formation of fibrillar and/or oligomeric Aβ in vitro. Of the three forms of curcumin liposomes tested, the click-curcumin type was by far the most effective. Liposomes with lipid ligands only inhibited Aβ fibril and oligomer formation at a very high ratio of liposome to peptide. Curcumin-based liposomes could be further developed as a novel treatment for Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“curcumin-containing nanoliposomes as well as other delivery systems have been designed and show to be very effective in reducing the Aβ fibrils formation (Taylor et al., 2011; Lazar et al., 2013; Mourtas et al., 2014; Shahbaz et al., 2021)”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Taylor et al., 2011
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Self-citationYang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802
Colorimetric determination of phospholipids with ammonium ferrothiocyanate
Stewart, J. C. M. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90269-9 · Cited by 1,786
Stability of curcumin in buffer solutions and characterization of its degradation products
Wang, Y., Pan, M., Cheng, A., Lin, L., Ho, Y., Hsieh, C., & Lin, J. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,709
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., Tharakan, S. T., Misra, K., Priyadarsini, K. I., Rajasekharan, K. N., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.008 · Cited by 1,205
Alzheimer's disease: strategies for disease modification
Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,075
The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform
Hong, S., Leroueil, P. R., Majoros, I., Orr, B. G., Baker, J. R., & Holl, M. M. B. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.015 · Cited by 585
Flagged first, then by citations
Cited by
Sorted by citations
Curcumin—From Molecule to Biological Function
Esatbeyoglu, T., Huebbe, P., Ernst, I. M. A., Chin, D., Wagner, A. E., & Rimbach, G. H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107724 · Cited by 921
Lee, W., Loo, C., Bebawy, M., Luk, F., Mason, R. S., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 552
Mathew, A., Fukuda, T., Nagaoka, Y., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., Venugopal, K., & Kumar, D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032616 · Cited by 454
Therapeutic Applications of Curcumin Nanoformulations
Yallapu, M. M., Nagesh, P. K. B., Jaggi, M., & Chauhan, S. C. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9811-z · Cited by 416
Protective effect of curcumin against heavy metals-induced liver damage
García‐Niño, W. R., & Pedraza‐Chaverrí, J. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.04.016 · Cited by 395
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305
Mourtas, S., Lazar, A. N., Markoutsa, E., Duyckaerts, C., & Antimisiaris, S. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.050 · Cited by 263
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro, R. G. R., Coutinho, A. J., Pinheiro, M., & Neves, A. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111654 · Cited by 251
Song, Q., Huang, M., Yao, L., Wang, X., Gu, X., Chen, J., Chen, J., Huang, J., Hu, Q., Kang, T., et al. (2014) · ACS Nano · doi:10.1021/nn4058215 · Cited by 219
Nanotechnology—novel therapeutics for CNS disorders
Srikanth, M., & Kessler, J. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.76 · Cited by 198
Liposome delivery systems for the treatment of Alzheimer’s disease
Ross, C., Taylor, M., Fullwood, N., & Allsop, D. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s183117 · Cited by 198
Self-citationCurcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases
Salehi, B., Călina, D. C., Docea, A. O., Koirala, N., Aryal, S., Lombardo, D., Pasqua, L., Taheri, Y., Castillo, C. M. S., Martorell, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020430 · Cited by 199
Curcumin and neurodegenerative diseases: a perspective
Darvesh, A. S., Carroll, R. T., Bishayee, A., Novotny, N. A., Geldenhuys, W. J., & der Schyf, C. J. V. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.693479 · Cited by 191
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 187
Nanotechnology for neurodegenerative disorders
Re, F., Gregori, M., & Masserini, M. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.015 · Cited by 174
Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System
Gao, H., Pang, Z., & Jiang, X. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1122-4 · Cited by 167
Palmal, S., Maity, A. R., Singh, B. K., Basu, S., Jana, N. R., & Jana, N. R. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201400079 · Cited by 157
Teixeira, M. I., Lopes, C. M., Amaral, M. H., & Costa, P. C. (2023) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2022.112999 · Cited by 154
Bana, L., Minniti, S., Salvati, E., Sesana, S., Zambelli, V., Cagnotto, A., Orlando, A., Cazzaniga, E., Zwart, R., Scheper, W., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.12.001 · Cited by 153
Lazar, A. N., Mourtas, S., Youssef, I., Parizot, C., Dauphin, A., Delatour, B., Antimisiaris, S. G., & Duyckaerts, C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.004 · Cited by 149
Ansari, N., & Khodagholi, F. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040005 · Cited by 132
Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview
Bilal, M., Barani, M., Sabir, F., Rahdar, A., & Kyzas, G. Z. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100251 · Cited by 131
Laurindo, L. F., de Carvalho, G. M., Zanuso, B. D. O., Figueira, M. E., Direito, R., Goulart, R. D. Á., Buglio, D. S., & Barbalho, S. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010229 · Cited by 133
Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule?
Serafini, M. M., Catanzaro, M., Rosini, M., Racchi, M., & Lanni, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.004 · Cited by 119
Mehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108
“Nanoliposomes of curcumin have high affinity for Aβ1-42 fibrils and were found to inhibit the formation of fibrillar and oligomeric Aβ in-vitro [101,102].”
BackgroundAdvances in developing therapeutic strategies for Alzheimer's disease
Nguyen, T. T., Nguyen, T. T. D., Nguyen, T. K. O., Vo, T. K., & Giau, V. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111623 · Cited by 108
Potential protective roles of curcumin against cadmium-induced toxicity and oxidative stress
Park, J. H., Lee, B. M., & Kim, H. S. (2020) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2020.1860842 · Cited by 106
Squillaro, T., Cimini, A., Peluso, G., Giordano, A., & Melone, M. A. B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.05.016 · Cited by 104
Nanomaterials and neurodegeneration
Migliore, L., Uboldi, C., Bucchianico, S. D., & Coppedè, F. (2015) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21931 · Cited by 104
Nanomedicine for the Treatment of Alzheimer’s Disease
Gregori, M., Masserini, M., & Mancini, S. (2015) · Nanomedicine · doi:10.2217/nnm.14.206 · Cited by 100
Novel concept of exosome-like liposomes for the treatment of Alzheimer's disease
Fernandes, M. S., Lopes, I., Magalhães, L., Sárria, M. P., Machado, R., Sousa, J. C., Botelho, C., Teixeira, J. A., & Gomes, A. C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.018 · Cited by 97
Kim, M., Shin, M., Zhao, Y., Ghosh, M., & Son, Y. (2024) · Small Science · doi:10.1002/smsc.202400280 · Cited by 97
Parthsarathy, V., McClean, P. L., Hölscher, C., Taylor, M., Tinker, C. L., Jones, G., Kolosov, O., Salvati, E., Gregori, M., Masserini, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054769 · Cited by 96
Abdel-Hafez, S. M., Hathout, R. M., & Sammour, O. A. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.03.051 · Cited by 90
Babazadeh, A., Vahed, F. M., & Jafari, S. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.015 · Cited by 90
Mitochondrial therapeutic interventions in Alzheimer’s disease
Giau, V. V., An, S. S. A., & Hulme, J. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.09.033 · Cited by 87
Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review
Mandal, M., Jaiswal, P., & Mishra, A. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22478 · Cited by 89
Nanotechnology for neurodegenerative disorders
Re, F., Gregori, M., & Masserini, M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.007 · Cited by 84
A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson’s Disease
Mittal, P., Dhankhar, S., Chauhan, S., Garg, N., Bhattacharya, T., Ali, M., Chaudhary, A. A., Rudayni, H. A., Al-Zharani, M. M., Ahmad, W., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16070908 · Cited by 93
Cadmium‐induced toxicity is rescued by curcumin: A review
Mohajeri, M., Rezaee, M., & Sahebkar, A. (2017) · BioFactors · doi:10.1002/biof.1376 · Cited by 84
Inhibition of Amyloid Fibril Growth by Nanoparticle Coated with Histidine-Based Polymer
Palmal, S., Jana, N. R., & Jana, N. R. (2014) · The Journal of Physical Chemistry C · doi:10.1021/jp505613g · Cited by 78
Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73
Bose, T., Latawiec, D., Mondal, P. P., & Mandal, S. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2527-7 · Cited by 71
Zheng, X., Zhang, C., Guo, Q., Xu, W., Shao, X., Liu, Q., & Zhang, Q. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.033 · Cited by 71
Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds
Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00694-3 · Cited by 75
Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 70
Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation
Shao, X., Yan, C., Wang, C., Wang, C., Cao, Y. Q., Zhou, Y., Guan, P., Hu, X., Zhu, W., & Ding, S. (2022) · Nanoscale Advances · doi:10.1039/d2na00625a · Cited by 63
Gregori, M., Taylor, M., Salvati, E., Re, F., Mancini, S., Balducci, C., Forloni, G., Zambelli, V., Sesana, S., Michael, M., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.10.006 · Cited by 65
Omidian, H., Cubeddu, L. X., & Wilson, R. L. (2025) · Molecules · doi:10.3390/molecules30071572 · Cited by 60
Rabanel, J., Faivre, J., Paka, G. D., Ramassamy, C., Hildgen, P., & Banquy, X. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.09.004 · Cited by 58
Kuo, Y.-C., & Lin, C.-C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79528 · Cited by 56
Nanotechnology-based herbal medicine: Preparation, synthesis, and applications in food and medicine
Awlqadr, F. H., Majeed, K. R., Altemimi, A. B., Hassan, A. M. A., Qadir, S. A., Saeed, M. N., Faraj, A. M., Salih, T. H., Al‐Manhel, A. J. A., Najm, M. A. A., et al. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101661 · Cited by 67
Markoutsa, E., Παπαδιά, Κ., Clemente, C., Flores, O., & Antimisiaris, S. G. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.006 · Cited by 56
Παπαδιά, Κ., Giannou, A. D., Markoutsa, E., Bigot, C., Vanhoute, G., Mourtas, S., der Linded, A. V., Stathopoulos, G. T., & Antimisiaris, S. G. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.010 · Cited by 56
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases
Smith, J. A., Leonardi, T., Huang, B., Iraci, N., Vega, B., & Pluchino, S. (2014) · Biogerontology · doi:10.1007/s10522-014-9510-7 · Cited by 55
Advances in nanotechnology for diagnosis and treatment of tuberculosis
Banyal, S., Malik, P., Tuli, H. S., & Mukherjee, T. K. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835eff08 · Cited by 53
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy
Tosi, G., Pederzoli, F., Belletti, D., Vandelli, M. A., Forni, F., Duskey, J. T., & Ruozi, B. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.001 · Cited by 53
Application of Nanodiagnostics and Nanotherapy to CNS Diseases
Zhang, W., Wang, W., Yu, D. X., Xiao, Z., & He, Z. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0163 · Cited by 51
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
Guo, Z.-H., Khattak, S., Rauf, M. A., Ansari, M. A., Alomary, M. N., Razak, S., Yang, C., Wu, D., & Ji, X. (2023) · Molecules · doi:10.3390/molecules28031283 · Cited by 49
Chakraborty, A., Mohapatra, S. S., Barik, S., Roy, I., Gupta, B., & Biswas, A. (2023) · Bioscience Reports · doi:10.1042/bsr20220324 · Cited by 47
Aloisio, C., Antimisiaris, S. G., & Longhi, M. R. (2016) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2016.12.035 · Cited by 45
Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects
Chopra, H., Bibi, S., Singh, I., Kamal, M. A., Islam, F., Alhumaydhi, F. A., Emran, T. B., & Cavalu, S. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879114 · Cited by 48
Nanoneuromedicine for management of neurodegenerative disorder
Dwivedi, N., Shah, J., Mishra, V. K., Tambuwala, M. M., & Kesharwani, P. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.12.021 · Cited by 44
Albadrani, H. M., Chauhan, P., Ashique, S., Babu, M. A., Iqbal, D., Almutary, A. G., Abomughaid, M. M., Kamal, M., Paiva‐Santos, A. C., Alsaweed, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116376 · Cited by 46
Liao, L., Shi, J., Jiang, C., Zhang, L., Feng, L., Liu, J., & Zhang, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.026 · Cited by 45
Mirzaie, Z., Ansari, M., Kordestani, S. S., Habibi-Rezaei, M., & Mozafari, M. (2019) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1751 · Cited by 44
Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides
Huang, Y., Chang, Y. K., Liu, L., & Wang, J. (2021) · Molecules · doi:10.3390/molecules26144301 · Cited by 43
Bandiwadekar, A., Jose, J., Khayatkashani, M., Habtemariam, S., Kashani, H. R. K., & Nabavi, S. M. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01922-7 · Cited by 44
Multifunctional LUV Liposomes Decorated for BBB and Amyloid Targeting. A. In Vitro Proof-of-Concept
Papadia, K., Markoutsa, E., Mourtas, S., Giannou, A. D., La Ferla, B., Nicotra, F., Salmona, M., Klepetsanis, P., Stathopoulos, G. T., & Antimisiaris, S. G. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.02.019 · Cited by 40
Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
Garbayo, E., de Mendoza, A. E., & Blanco‐Prieto, M. J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140815124246 · Cited by 38
Delivery systems for theranostics in neurodegenerative diseases
Li, Y., Liu, R., Ji, W., Li, Y., Liu, L., & Zhang, X. (2018) · Nano Research · doi:10.1007/s12274-018-2067-z · Cited by 35
Nanotherapeutic strategies for the treatment of neurodegenerative diseases
Huang, M., Gu, X. Q., & Gao, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00013-5 · Cited by 34
Far, B. F., Safaei, M., Pourmolaei, A., AdibAmini, S., Shirdel, S., Shirdel, S., Emadi, R., & Kaushik, A. K. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00112 · Cited by 37
Alzheimer’s disease: review of current nanotechnological therapeutic strategies
Baranowska‐Wójcik, E., & Szwajgier, D. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1719069 · Cited by 35
Nanotechnology in the diagnostic and therapy for Alzheimer's disease
Panghal, A., & Flora, S. J. S. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130559 · Cited by 31
Wang, Z., Sreenivasmurthy, S. G., Song, J., Liu, J.-Y., & Li, M. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.001 · Cited by 31
Curcumin – vom Molekül zur biologischen Wirkung
Esatbeyoglu, T., Huebbe, P., Ernst, I. M. A., Chin, D., Wagner, A. E., & Rimbach, G. H. (2012) · Angewandte Chemie · doi:10.1002/ange.201107724 · Cited by 30
Nanomedicine applications in women's health: state of the art
Lloyd-Parry, O., Downing, C., Aleisaei, E., Jones, C., & Coward, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s97572 · Cited by 31
Re, F., Antonina, O., Sesana, Rivolta, I., Panariti, Brambilla, Nicolas, J., Couvreur, Andrieux, K., Masserini, et al. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40297 · Cited by 29
Pillai, S. C., Borah, A., Jacob, E. M., & Kumar, D. S. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1892241 · Cited by 29
Airoldi, C., Mourtas, S., Cardona, F., Zona, C., Sironi, E., D’Orazio, G., Markoutsa, E., Nicotra, F., Antimisiaris, S. G., & Ferla, B. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.085 · Cited by 31
Cheikh‐Ali, Z., Caron, J., Cojean, S., Bories, C., Couvreur, P., Loiseau, P. M., Desmaële, D., Poupon, E., & Champy, P. (2014) · ChemMedChem · doi:10.1002/cmdc.201402449 · Cited by 27
Parthsarathy, V., McClean, P. L., Hölscher, C., Taylor, M., Tinker, C. L., Jones, G., Kolosov, O., Salvati, E., Gregori, M., Masserini, M., et al. (2013) · PLoS ONE · doi:10.1371/annotation/57e0a947-8600-4658-b04c-cf7a45c8bd8d · Cited by 27
Khot, K. B., Gopan, G., Bandiwadekar, A., & Jose, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101806 · Cited by 28
Modern aspects of the use of natural polyphenols in tumor prevention and therapy
Суфианова, Г. З., Фанилевич, Г. И., Beylerli, O., Wu, J., Shumadalova, A. V., Sufianov, A. A., Chen, X., & Zhao, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1011435 · Cited by 28
Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants
Prasad, K. N., & Bondy, S. C. (2014) · Current Aging Science · doi:10.2174/1874609807666140804115633 · Cited by 24
Development and application of nano-flavor-drug carriers in neurodegenerative diseases
Ji, W., Xiao, Z.-B., Liu, G., & Zhang, X. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.06.024 · Cited by 22
Kuo, Y., & Liu, Y. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.003 · Cited by 21
Nanopharmaceuticals: Innovative theranostics for the neurological disorders
Hassanzadeh, P. (2014) · Biomedical Reviews · doi:10.14748/bmr.v25.1043 · Cited by 21
Drugs and drug delivery systems targeting amyloid-β in Alzheimer's disease
Robinson, M. J., Lee, B. Y., & Leonenko, Z. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.3.332 · Cited by 24
Akkol, E. K., Bardakçı, H., Yücel, Ç., Karatoprak, G. Ş., Karpuz, B., & Khan, H. Z. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6168199 · Cited by 22
Polyphenols in the Central Nervous System: Cellular Effects and Liposomal Delivery Approaches
Kaluza, M., Ksiazek-Winiarek, D. J., Szpakowski, P., Czpakowska, J., Fijalkowska, J., & Glabinski, A. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136477 · Cited by 28
Kanojia, N., Thapa, K., Kaur, G., Sharma, A., Puri, V., & Verma, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104074 · Cited by 19
Elawad, M. A., Ayaz, M., Mosa, O. F., Usman, A., Hamdoon, A. A. E., Almawash, S., Salim, L. H. M., Ahmed, A., & Elkhalifa, M. E. M. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400525 · Cited by 20
Molecular dynamic studies of amyloid-beta interactions with curcumin and Cu2+ ions
Kozmon, S., & Tvaroška, I. (2015) · Chemical Papers · doi:10.1515/chempap-2015-0134 · Cited by 18
Reich, N., Allsop, D., Parkin, E. T., & Dawson, N. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18477 · Cited by 14
Mourtas, S., Mavroidi, B., Marazioti, A., Kannavou, M., Sagnou, M., Pelecanou, M., & Antimisiaris, S. G. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00811 · Cited by 14
Gao, C., Liu, Y., Zhang, T., Luo, Y., Gao, J., Chu, J., Gong, B., Chen, X., Yin, T., Zhang, J., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s436774 · Cited by 16
Ortiz-Islas, E., Montes, P., Rodríguez-Pérez, C. E., Ruiz-Sánchez, E., Sánchez-Barbosa, T., Pichardo-Rojas, D., Zavala‐Tecuapetla, C., Carvajal, K., & Campos‐Peña, V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010128 · Cited by 14
Curcumin Reduces Amyloid Beta Oligomer Interactions with Anionic Membranes
Sallaberry, C. A., Voss, B. J., Stone, W. B., Estrada, F., Bhatia, A., Soto, J. D., Griffin, C. W., & Zanden, C. M. V. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00512 · Cited by 11
Metadata
- Authors
- Taylor, M., Moore, S., Mourtas, S., Niarakis, A., Re, F., Zona, C., Ferla, B. L., Nicotra, F., Masserini, M., Antimisiaris, S. G., Gregori, M., & Allsop, D.
- Affiliations
- Lancaster University (GB)
- University of Patras (GR)
- University of Milano-Bicocca (IT)
- Corresponding author
- Allsop, David
- ORCID
- Venue
- Nanomedicine Nanotechnology Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 7
- Issue
- 5
- Pages
- 541-550
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W2082371846
- Cited by
- 149
- References
- 46
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 10 · 2023: 9 · 2022: 13 · 2021: 9 · 2020: 12 · 2019: 9 · 2018: 13 · 2017: 9 · 2016: 4 · 2015: 10 · 2014: 17 · 2013: 9 · 2012: 10
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nanomedicine Nanotechnology Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- Funders
- Seventh Framework Programme (212043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- curcumin, nanoliposomes, amyloid-beta 42, peptide aggregation inhibition, Alzheimer's disease, phosphatidic acid, cardiolipin, GM1 ganglioside, click chemistry, fibril formation, oligomerization, lipid ligands, nanomedicine
- MeSH terms
- Alzheimer Disease, Cardiolipins, Curcumin, G(M1) Ganglioside, Humans, Ligands, Liposomes, Peptide Fragments, Phosphatidic Acids, Amyloid beta-Peptides, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
